Antimicrobial Susceptibility of Klebsiella pneumoniae and Escherichia coli with Extended-Spectrum β-lactamase associated Genes in Hospital Tengku Ampuan Afzan, Kuantan, Pahang
- PMID: 27547110
- PMCID: PMC4976709
Antimicrobial Susceptibility of Klebsiella pneumoniae and Escherichia coli with Extended-Spectrum β-lactamase associated Genes in Hospital Tengku Ampuan Afzan, Kuantan, Pahang
Abstract
Background: To assess antimicrobial susceptibility of extended-spectrum β-lactamase- (ESBL-) producing Klebsiella pneumoniae and Escherichia coli isolates from Hospital Tengku Ampuan Afzan (HTAA), as well as to identify ESBL genes.
Methods: Non-duplicate K. pneumoniae and E. coli isolates were recovered from various clinical samples. Isolates were screened for antimicrobial resistance by disc diffusion method. Isolates resistant to oxyimino-cephalosporins were subjected to phenotypic ESBL production. Detection of resistance genes was then performed using primers specific for ESBL genes (bla CTX-M, bla SHV and bla TEM).
Results: Piperacillin/tazobactam and carbapenems remained the active β-lactam antibiotic against K. pneumoniae and E. coli. ESBLs were detected among 35.5% (39/110) of K. pneumoniae and 18.8% (28/149) of E. coli isolates. CTX-M β-lactamase was detected in 90% of all ESBL-positive isolates, whereas bla SHV and bla TEM genes were found among 56% and 52% of them, respectively. Twenty-eight percent (28%) of the total ESBL-positive isolates harboured the three ESBL genes, while 50% carried two of the tested ESBL genes.
Conclusion: ESBLs encoded by at least one ESBL genes are frequently isolated among K. pneumoniae and E. coli in HTAA. The significant proportion rate of these resistant determinants is alarming, thus monitoring their transmission and dissemination is essential to control it at an early phase.
Keywords: Escherichia coli; Klebsiella pneumoniae; antimicrobial resistance; beta-Lactamases; hospital.
Similar articles
-
Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.J Med Assoc Thai. 2011 Dec;94(12):1504-12. J Med Assoc Thai. 2011. PMID: 22295740
-
Integron-mediated multidrug resistance in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from fecal specimens in Egypt.J Egypt Public Health Assoc. 2016 Jun;91(2):73-9. doi: 10.1097/01.EPX.0000483165.56114.d8. J Egypt Public Health Assoc. 2016. PMID: 27455084
-
Antibiotic susceptibility pattern and identification of extended spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae from Shiraz, Iran.Iran J Microbiol. 2016 Feb;8(1):55-61. Iran J Microbiol. 2016. PMID: 27092225 Free PMC article.
-
Identification and characterization of CTX-M-15 producing Klebsiella pneumoniae clone ST101 in a Hungarian university teaching hospital.Acta Microbiol Immunol Hung. 2015 Sep;62(3):233-45. doi: 10.1556/030.62.2015.3.2. Acta Microbiol Immunol Hung. 2015. PMID: 26551567 Review.
-
Prevalence and genetic characterization of clinically relevant extended-spectrum β-lactamase-producing Enterobacterales in the Gulf Cooperation Council countries.Front Antibiot. 2023 Jun 26;2:1177954. doi: 10.3389/frabi.2023.1177954. eCollection 2023. Front Antibiot. 2023. PMID: 39816644 Free PMC article. Review.
Cited by
-
Gut colonization and subsequent infection of neonates caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.Front Cell Infect Microbiol. 2024 Jan 19;13:1322874. doi: 10.3389/fcimb.2023.1322874. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38314094 Free PMC article.
-
Characterisation of Bacterial Isolates from Infected Post-Operative Patients in a Malaysian Tertiary Heart Care Centre.Int J Environ Res Public Health. 2021 Sep 17;18(18):9828. doi: 10.3390/ijerph18189828. Int J Environ Res Public Health. 2021. PMID: 34574752 Free PMC article.
-
"Two Is Better Than One": The Multifactorial Nature of Phage-Antibiotic Combinatorial Treatments Against ESKAPE-Induced Infections.Phage (New Rochelle). 2023 Jun 1;4(2):55-67. doi: 10.1089/phage.2023.0007. Epub 2023 Jun 19. Phage (New Rochelle). 2023. PMID: 37350995 Free PMC article. Review.
-
In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Associated with Urinary Tract Infections in Malaysia.Antibiotics (Basel). 2021 Feb 11;10(2):181. doi: 10.3390/antibiotics10020181. Antibiotics (Basel). 2021. PMID: 33670224 Free PMC article.
-
ESBL Production Among E. coli and Klebsiella spp. Causing Urinary Tract Infection: A Hospital Based Study.Open Microbiol J. 2017 Apr 28;11:23-30. doi: 10.2174/1874285801711010023. eCollection 2017. Open Microbiol J. 2017. PMID: 28553414 Free PMC article.
References
-
- Paterson DL. Resistance in gram-negative bacteria: enterobacteriaceae. Am J Med. 2006;119(6 Suppl 1):S20–28. - PubMed
-
- Zhou T, Zhang X, Guo M, Ye J, Lu Y, Bao Q, et al. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China. Jpn J Infect Dis. 2013;66(2):96–102. - PubMed
-
- Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs. 2003;63(4):353–365. - PubMed
LinkOut - more resources
Full Text Sources